Maximilian P.Krause

Partner

Munich + 49.89.20.60.42.200

Connect:

Share

Maximilian Krause has in-depth experience handling major national and international M&A, private equity, and venture capital transactions (acquisitions, divestments, joint ventures, corporate transformations, financing rounds) as well as domestic and cross-border business reorganizations. He advises leading industrial clients, investors, and portfolio companies on corporate, transactional, and restructuring matters and coordinates the multiple aspects of complex deals for them.

Maximilian's recent representations include advising SAP on a joint venture with Dediq in the financial and insurance sector (volume approximately €500 million); the acquisition by STERIS of Cantel Medical for US$3.6 billion; the sale by Solvay of its barium, strontium, and sodium percarbonate businesses to Latour Capital; the sale by Verizon of its cloud and managed hosting service to IBM; the sale by Cardinal Health of its Cordis business to Hellman & Friedman (approximately US$1 billion); a joint venture between Safran and Airbus Group regarding the development of space launchers (e.g., Ariane 6); and the sale of Procter & Gamble's beauty brands to Coty for US$12.5 billion. Maximilian regularly advises KWS SAAT, MAHLE, CBRE, Koch Industries, Tenneco, Boeing, GfK, Findos, and Nordson.

Prior to joining Jones Day, Maximilian worked in the Munich, Frankfurt, and Düsseldorf offices of another leading international law firm. During this time he represented numerous notable companies, including Siemens and Haniel in several large carve-outs, restructurings, and disposals of various business lines worldwide. He also advised Volkswagen, Linde, KKR, Nokia, EWE, 3i, UniCredit, Barclays PE (now Equistone), Colony Capital, FTI Consulting, IK Partners, IVG, VSS, Mecom, and Pioneer Investments.

Experience

  • Affiliates of Centre Lane Partners acquire substantially all of the assets of Hardinge Inc. and its subsidiaries, including the Kellenberger, USACH, SuperPrecision, and Workholding business linesJones Day advised affiliates of Centre Lane Partners in the acquisition of substantially all of the assets of Hardinge Inc. and its debtor subsidiaries, a global leader and provider of advanced machine tool, manufacturing and workholding solutions, as part of chapter 11 proceedings in the United States Bankruptcy Court for the District of Delaware.
  • STERIS sells dental segment to an affiliate of Peak Rock CapitalJones Day advised STERIS Plc in the $787.5 million sale of Dental segment to Peak Rock Capital, a leading middle-market private investment firm.
  • Diebold Nixdorf obtains $1.25 billion senior secured exit credit facilityJones Day represented Diebold Nixdorf, Incorporated, a multinational financial and retail technology company that specializes in the sale, manufacture, installation, and service of self-service transaction systems (such as ATMs and currency processing systems), point-of-sale terminals, physical security products, and software and related services for global financial, retail, and commercial markets, in connection with a new $1.25 billion senior secured term loan facility as part of it’s emergence from chapter 11 bankruptcy and other domestic and foreign court-supervised restructuring proceedings.
  • Diebold Nixdorf successfully restructures over $2.7 billion in funded debt and completes the first-ever dual proceeding under the U.S. bankruptcy code and Dutch restructuring law in 71 daysIn the first-ever cross border restructuring involving dual main proceedings under chapter 11 of the U.S. Bankruptcy Code and a scheme of arrangement (the "Dutch Scheme") under the Dutch Act on Confirmation of Extrajudicial Plans (Wet Homologatie Onderhands Akkoord ("WHOA")), and the first-ever chapter 15 recognition of Dutch Scheme proceedings and a sanctioned WHOA reorganization plan (the "WHOA Plan"), Jones Day represented Diebold Nixdorf, Incorporated ("Diebold") and certain of its U.S. and Canadian subsidiaries (the "Debtors") in connection with (i) the prepackaged chapter 11 cases of In re Diebold Holding Company, LLC, et al., (Case No. 23-90602-DRJ) commenced on June 1, 2023, in the United States Bankruptcy Court for the Southern District of Texas (the "Bankruptcy Court"); (ii) the Dutch Scheme, commenced on June 1, 2023 by Diebold Nixdorf Dutch Holding B.V. (the "Dutch Issuer") in the District Court of Amsterdam (the "Dutch Court"), and (iii) the chapter 15 proceedings before the Bankruptcy Court commenced by the foreign representative of the Dutch Issuer, wherein the Bankruptcy Court recognized the Dutch Scheme proceeding as a foreign main proceeding and recognized and extended comity to the WHOA Plan that was sanctioned by the Dutch Court.
  • Diebold Nixdorf obtains $1.25 billion senior secured superpriority DIP credit facilityJones Day is representing Diebold Nixdorf, Incorporated (the “Company”), a multinational financial and retail technology company that specializes in the sale, manufacture, installation, and service of self-service transaction systems (such as ATMs and currency processing systems), point-of-sale terminals, physical security products, and software and related services for global financial, retail, and commercial markets, and certain of its domestic and foreign subsidiaries (collectively, the “Debtors”) in (i) a pre-packaged chapter 11 proceeding in front of the U.S. Bankruptcy Court for the Southern District of Texas (the “Bankruptcy Court”), (ii) a scheme of arrangement by Diebold Nixdorf Dutch Holding B.V. (the “Dutch Issuer”) and the related voluntary proceeding in front of the District Court of Amsterdam under the Dutch Act on Confirmation of Extrajudicial Plans (Wet Homologatie Onderhands Akkoord), and (iii) an anticipated proceeding commenced by the Dutch Issuer under chapter 15 in the Bankruptcy Court, seeking recognition of such scheme of arrangement.
  • Findos Investor sells Rhenoflex GmbH to Coats GroupJones Day advised Findos Investor GmbH in the €115 million sale of Rhenoflex GmbH, one of the leading global manufacturers of sustainable structural material solutions for the footwear industry, to Coats Group plc.
  • Arrowhead Engineered Products acquires Best4ForstJones Day advised Arrowhead Engineered Products, Inc. in the acquisition of Best4Forst, a firm serving the European market with forestry and outdoor power equipment parts ranging from robomowers to commercial logging equipment.
  • Arsenal acquires ATP Group from Bregal UnternehmerkapitalJones Day advised Arsenal Capital Partners in the acquisition of ATP Group, a leading Swiss based manufacturer of water-based adhesive tapes, from Bregal Unternehmerkapital.
  • SAP forms strategic partnership with Dediq for financial services industriesJones Day advised SAP in the formation of SAP Fioneer, a joint venture with the Munich based investor DEDIQ GmbH whereby SAP contributed its Financial Services and Insurance Services business and DEDIQ will invest more than €500 million.
  • Cardinal Health sells its Cordis business to Hellman & Friedman for approximately $1 billionJones Day advised Cardinal Health in connection with the divestiture of its Cordis business to Hellman & Friedman for approximately $1 billion.
  • Parkwind obtains financing for 257 MW Arcadis Ost 1 offshore wind farmJones Day advised Parkwind NV, an independent green energy company that develops, finances, and operates offshore wind farms, on the financing of the 257 MW Arcadis Ost 1 offshore wind farm.
  • STERIS acquires Cantel Medical for $3.6 billionJones Day advised STERIS plc in its acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers, for $3.6 billion.
  • Solvay sells barium, strontium and sodium percarbonate businesses to Latour CapitalJones Day advised Solvay S.A., a publicly listed chemical company based in Brussels, Belgium, on the combined sale of its technical-grade barium and strontium business in Germany, Spain and Mexico, and its sodium percarbonate business in Germany to Latour Capital.
  • Nordson sold screws and barrels product line to Altair InvestmentsJones Day advised Nordson Corporation in the sale of its screws and barrels product line from its polymer processing systems division to Altair Investments.
  • Verint Systems separates into two independent companiesJones Day advised Verint® Systems Inc. ("Verint") in the separation and spin-off of its cyber intelligence business, Cognyte Systems Ltd.
  • STERIS acquires Key Surgical for approximately $850 millionJones Day advised STERIS plc (NYSE: STE) in the $850 million acquisition of Key Surgical, a leading global provider of sterile processing, operating room, and endoscopy products, and a portfolio company of Water Street Healthcare Partners, LLC.
  • Koch-Glitsch acquired Julius Montz from Pfaudler GroupJones Day advised Koch-Glitsch, a subsidiary of Koch Engineered Solutions (KES) and its parent company Koch Industries, Inc., in the acquisition of chemical and pharmaceutical process equipment and technology supplier Julius Montz GmbH (Montz) from the Pfaudler Group, a portfolio company of Deutsche Beteiligungs AG (DBAG).
  • KWS and J.R. Simplot Company establish joint venture for hybrid potato breedingJones Day advised KWS SAAT SE in the formation of a joint venture company, Aardevo B.V., with J.R. Simplot Company to deliver top performing potato varieties through hybrid breeding.
  • Molex acquires Laird Connected Vehicle Solutions divisionJones Day advised Molex Electronic Technologies, LLC, a leading global manufacturer of electronic solutions, on its acquisition of the Connected Vehicle Solutions division of Laird Limited.
  • Georgia-Pacific sells European nonwovens business to Glatfelter for $185 millionJones Day advised Georgia-Pacific LLC ("GP") in the sale of its European nonwovens business to Glatfelter, a global manufacturer of specialty papers and engineered products, for $185 million.
    • View All

    October 2017 Commentary

    Drones Over Europe: A Regulatory Overview

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.